MedPath

A clinical trial to study the effects of two massages, manual and myofacial release in reducing shoulder pain and stiffness among breast cancer patients received surgery and radiotherapy treatment

Not Applicable
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Registration Number
CTRI/2022/03/040985
Lead Sponsor
Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Consenting women above 18 years of age with breast cancer undergone breast cancer surgery followed by radiotherapy.

2.Up to stage 1 lymphedema

3.Pain following radiotherapy along with one or more of the following symptoms: heaviness, numbness, oppression, stiffness, alterations in the function, or mobility of the shoulder

Exclusion Criteria

1.Women with muscle or tendon injuries in the ipsilateral arm and/or neck.

2.Skin conditions (Local or generalized infection, eczema, psoariasis, etc) which will make myofascial release difficult.

3.Circulatory pathologies (thrombus, embolus of upper limb, on anticoagulants).

4.Surgical history in the ipsilateral shoulder, neck, or chest.

5.Participating in another clinical trial that interferes with the primary and/or secondary outcome of this trial.

6.Breast cancer partially treated elsewhere.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the short and mid-term effectiveness of breast cancer specific myofascial release and manual lymphatic drainage with respect to: <br/ ><br>1.Pain in the chest wall and upper limb assessed by visual analogue scale <br/ ><br>2.Mobility of the shoulder joint assessed using a goniometer. <br/ ><br>Timepoint: Three assessment 1. before beginning of the treatment (T0) 2. After completion of the treatment 4 weeks (T1). 3. Follow-up 1 month after completion of the treatment (T2).
Secondary Outcome Measures
NameTimeMethod
To compare the short and mid-term effects of breast cancer specific myofascial release compared to manual lymphatic drainage in terms of <br/ ><br> <br/ ><br>1. Functionality of the upper limb assesed using Disability of Arm, shoulder and Hand (DASH) score <br/ ><br> <br/ ><br>2. Quality of life assessed using functional assessment of cancer and Arm subscle (FACT B4) Questionnaire <br/ ><br>Timepoint: Three assessment 1. before beginning of the treatment (T0) 2. After completion of the treatment 4 weeks (T1). 3. Follow-up 1 month after completion of the treatment (T2).
© Copyright 2025. All Rights Reserved by MedPath